VisionSys AI Inc

Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.

VSA | US

Overview

Corporate Details

ISIN(s):: US8761081012
LEI:
Country:: United States of America
Address:: 2 HAMMARSKJOLD PLAZA, ROOM 10B, 10017 NEW YORK
Website:: https://ir.tctm.cn/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

VisionSys AI Inc. is an emerging technology services company specializing in the development and application of advanced artificial intelligence. Formerly a provider of STEM education, the company has pivoted its focus to brain-machine interaction (BMI) and brain-computer interface (BCI) businesses, leveraging proprietary core algorithms. VisionSys is also dedicated to advancing AI-powered solutions for the healthcare and biotech sectors. The company actively explores the strategic integration of AI with blockchain and Web3 technologies to drive digital transformation and accelerate ecosystem growth.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VisionSys AI Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VisionSys AI Inc

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for VisionSys AI Inc via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PhoenixBio Co.,Ltd. CRO providing humanized liver mouse models and testing services for preclinical drug development.	Japan	6190
P&K Skin Research Center Co.,Ltd. Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.	South Korea	347740
Plantarc Bio Ltd. Developing high-yield, resilient crops via gene discovery for global seed companies.	Israel	PLNT
Polymetal International plc A top global gold and silver producer with mining and exploration operations in Kazakhstan.	Kazakhstan	POLY
Poxel Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.	France	POXEL
PRAP Japan,Inc. A PR & communications firm building brand reputation for corporate clients in diverse industries.	Japan	2449
Predictive Oncology Inc. AI platform uses a vast tumor biobank to predict drug response and accelerate oncology discovery.	United States of America	POAI
Prime Medicine, Inc. Developing 'search and replace' gene editing therapies to treat genetic disorders.	United States of America	PRME
ProPhase Labs, Inc. Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.	United States of America	PRPH
PROTHENA CORP PUBLIC LTD CO Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.	United States of America	PRTA